Explore the history of psychedelic research in the U.S., the rise of prohibition in the 70s, and the renewed hope for mental health. Learn about the current state of legalization, medicalization, and commercialization of psychoactives in the US, and why the FDA recently denied MDMA approval for PTSD treatment. Our Speaker: Bev is a current Master’s student at the University of Wisconsin School of Pharmacy in Psychoactive Pharmaceuticals, advocate and speaker on psychoactive-assisted therapies for PTSD and depression. Experienced wellness instructor with a background in biochemistry, holistic nutrition, and mental healthcare access.